Results 61 to 70 of about 46,622 (140)

Distinct agonist regulation of muscarinic acetylcholine M2-M3 heteromers and their corresponding homomers [PDF]

open access: yes, 2015
Each subtype of the muscarinic receptor family of G protein-coupled receptors is activated by similar concentrations of the neurotransmitter acetylcholine or closely related synthetic analogs such as carbachol. However, pharmacological selectivity can be
Alvarez-Curto, Elisa   +3 more
core   +1 more source

Deduction of Novel Genes Potentially Involved in the Effects of Very Low Dose Atropine (0.003%) Treatment on Corneal Epithelial Cells Using Next-Generation Sequencing and Bioinformatics Approaches

open access: yesMedicina, 2019
Background and Objectives: Atropine is a nonselective muscarinic antagonist which has been used to prevent worsening of myopia in children. Different concentrations of atropine were used for myopia, ranging from 0.01% to 1.0%.
Wei-An Chang   +5 more
doaj   +1 more source

Vagolytic atropine attenuates cerebral vasodilation response during acute orthostatic hypotension [PDF]

open access: yesKorean Journal of Anesthesiology, 2015
BackgroundAtropine is an anticholinergic drug which is commonly used in clinical practice. The effect of parasympathetic block with atropine on dynamic cerebrovascular regulation remains unclear.
Woo-Jong Choi   +5 more
doaj   +1 more source

Effects of atropine 0.01% on refractive errors in children with myopia

open access: yesHeliyon, 2023
Background: Little is known about changes in astigmatism during atropine treatment. We aimed to explore the effects of atropine 0.01% eye drops on both spherical and cylindrical refractive errors in myopic children. Methods: Children aged 6–14 years with
Xingxue Zhu   +5 more
doaj   +1 more source

Effect of Methoxime Combined with Anticholinergic, Anticonvulsant or Anti-HCN Drugs in Tabun-Poisoned Mice

open access: yesActa Medica, 2003
The effect of methoxime combined with a) atropine, b) benactyzine, c) atropine and natrium thiosulphate, d) atropine and diazepam on antidotal treatment effectiveness was studied in tabun-poisoned mice.
Lucie Ševelová, Josef Vachek
doaj   +1 more source

Stability of Ophthalmic Atropine Solutions for Child Myopia Control

open access: yesPharmaceutics, 2020
Myopia is an ophthalmic condition affecting more than 1/5th of the world population, especially children. Low-dose atropine eyedrops have been shown to limit myopia evolution during treatment.
Baptiste Berton   +6 more
doaj   +1 more source

Effects of novel muscarinic M3 receptor ligand C1213 in pulmonary arterial hypertension models. [PDF]

open access: yes, 2016
Pulmonary hypertension (PH) is a complex disease comprising a pathologic remodeling and thickening of the pulmonary vessels causing an after load on the right heart ventricle that can result in ventricular failure. Triggered by oxidative stress, episodes
Ahmed, Mohamed   +5 more
core   +2 more sources

Carbachol increases intracellular free calcium concentrations in human granulosa-lutein cells [PDF]

open access: yes, 1992
We investigated whether the stimulation of human granulosa-lutein cells with muscarinic and nicotinic receptor agonists can cause increases in intracellular free calcium (Ca2+), using Fura-2 microfluorimetry.
Föhr, K. J.   +3 more
core   +1 more source

Stepwise low concentration atropine for myopic control: a 10-year cohort study

open access: yesScientific Reports, 2021
The aim of this study was to analyze changes in refraction and evaluate the variables in school children who received atropine as myopic control for 10 years.
Meng-Ni Chuang   +2 more
doaj   +1 more source

An in vivo biosensor for neurotransmitter release and in situ receptor activity. [PDF]

open access: yes, 2010
Tools from molecular biology, combined with in vivo optical imaging techniques, provide new mechanisms for noninvasively observing brain processes. Current approaches primarily probe cell-based variables, such as cytosolic calcium or membrane potential ...
Griesbeck, Oliver   +6 more
core   +2 more sources

Home - About - Disclaimer - Privacy